Medartis: Profile of a Newly-Public Orthopaedic Company

By Carolyn LaWell

Medartis went public on the SIX Swiss Exchange in March, securing proceeds to fund product development, international expansion and potential acquisitions. Their public launch provided deeper insight into the company's position within the global orthopaedic trauma space. We reviewed Medartis' 2017 and 2018 strategic announcements, and spoke with leadership to get a better sense of the company's recent and future movement.

Member-Only Content

SUBSCRIBE Login

Tags: Revenue Report